Drug treatments for covid-19: living systematic review and network meta-analysis

RA, Siemieniuk; JJ, Bartoszko; D, Zeraatkar; E, Kum; A, Qasim; JPD, Martinez; A, Izcovich; F, Lamontagne; F, Lamontagne; MA, Han; A, Agarwal; T, Agoritsas; M, Azab; G, Bravo; DK, Chu; R, Couban; R, Couban; T, Devji; Z, Escamilla; F, Foroutan; Y, Gao; L, Ge; M, Ghadimi; D, Heels-Ansdell; K, Honarmand; L, Hou; Q, Ibrahim; A, Khamis; B, Lam; C, Mansilla; C, Mansilla; M, Loeb; A, Miroshnychenko; M, Marcucci; SL, McLeod; SL, McLeod; S, Motaghi; S, Murthy; RA, Mustafa; H, Pardo-Hernandez; G, Rada; Y, Rizwan; P, Saadat; C, Switzer; L, Thabane; G, Tomlinson; PO, Vandvik; RW, Vernooij; RW, Vernooij; A, Viteri-García; Y, Wang; L, Yao; Y, Zhao; GH, Guyatt; R, Brignardello-Petersen

doi:10.1136/bmj.m2980

Public

Drug treatments for covid-19: living systematic review and network meta-analysis

Shared by NobleBlocks on Jul 30, 2020 • 12:00 AM UTC

Authors:

Siemieniuk RA

Bartoszko JJ

Zeraatkar D

Abstract

Objective To compare the effects of treatments for coronavirus disease 2019 (covid-19).Design Living systematic review and network meta-analysis.Data sources WHO covid-19 database, a comprehensive multilingual source of global covid-19 literature, up to 3 December 2021 and six additional Chinese dat...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!